Ian Tannock
Ian Tannock
Princess Margaret Hospital
Verified email at uhn.ca
TitleCited byYear
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock, R De Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, ...
New England Journal of Medicine 351 (15), 1502-1512, 2004
56952004
Drug penetration in solid tumours
AI Minchinton, IF Tannock
Nature Reviews Cancer 6 (8), 583-592, 2006
21202006
Enzalutamide in metastatic prostate cancer before chemotherapy
TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ...
New England Journal of Medicine 371 (5), 424-433, 2014
18532014
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
IF Tannock, D Osoba, MR Stockler, DS Ernst, AJ Neville, MJ Moore, ...
Journal of Clinical Oncology 14 (6), 1756-1764, 1996
18291996
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical …
HI Scher, S Halabi, I Tannock, M Morris, CN Sternberg, MA Carducci, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
17932008
Acid pH in tumors and its potential for therapeutic exploitation
IF Tannock, D Rotin
Cancer research 49 (16), 4373-4384, 1989
17471989
Drug resistance and the solid tumor microenvironment
O Trédan, CM Galmarini, K Patel, IF Tannock
Journal of the National Cancer Institute 99 (19), 1441-1454, 2007
16172007
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri, J Nemunaitis, I Ganly, J Arseneau, IF Tannock, L Romel, ...
Nature medicine 6 (8), 879-885, 2000
12752000
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ...
JNCI: Journal of the National Cancer Institute 106 (6), 2014
11422014
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
DR Berthold, GR Pond, F Soban, R De Wit, M Eisenberger, IF Tannock
Journal of Clinical Oncology 26 (2), 242-245, 2008
11352008
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative …
PJ Loehrer Sr, LH Einhorn, PJ Elson, ED Crawford, P Kuebler, I Tannock, ...
J Clin Oncol 10 (7), 1066-1073, 1992
10211992
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
C Zimmermann, N Swami, M Krzyzanowska, B Hannon, N Leighl, A Oza, ...
The Lancet 383 (9930), 1721-1730, 2014
9342014
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.
IF Tannock
British journal of cancer 22 (2), 258, 1968
9291968
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
6042011
Cognitive function in breast cancer patients receiving adjuvant chemotherapy
CB Brezden, KA Phillips, M Abdolell, T Bunston, IF Tannock
Journal of Clinical Oncology 18 (14), 2695-2701, 2000
6022000
Repopulation of cancer cells during therapy: an important cause of treatment failure
JJ Kim, IF Tannock
Nature Reviews Cancer 5 (7), 516-525, 2005
5922005
Bone metastases: pathophysiology and management policy.
OS Nielsen, AJ Munro, IF Tannock
Journal of clinical oncology 9 (3), 509-524, 1991
5831991
Cytokines and their relationship to the symptoms and outcome of cancer
B Seruga, H Zhang, LJ Bernstein, IF Tannock
Nature Reviews Cancer 8 (11), 887-899, 2008
5702008
The basic science of oncology
IF Tannock
McGraw-Hill, 2005
5632005
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial …
SB Saxman, KJ Propert, LH Einhorn, ED Crawford, I Tannock, ...
Journal of Clinical Oncology 15 (7), 2564-2569, 1997
5421997
The system can't perform the operation now. Try again later.
Articles 1–20